LexDanaLexDanabeta
Inventor

Harald Fricke

Inventor
Mannheim, DE

Overview

4→
Patents
2017–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
PatentTitleYear
11,014,991Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody202110,428,154Monoclonal anti-CD95L antibody201910,266,600Diagnostic anti-CD95L antibody20199,540,431'Inhibitors of the CD95 signaling pathway for treatment of MDS'2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2021Patents assigned to APOGENIX AG (4)· patent assignee history
2017Patents assigned to APOGENIX GMBH (1)· patent assignee history
2017–2021Based in Mannheim, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
APOGENIX AG42017–2021
APOGENIX GMBH12017
Locations
LocationPatentsSpan
Mannheim, DE42017–2021